IP Library › Assignment 033118/0499
Patent Assignment
Reel/Frame 033118/0499

Assignment of Assignor's Interest

Recorded: 2014-06-03 Pages: 7
Assignor
THERAVANCE, INC.
Executed: 2014-06-01
Assignee
THERAVANCE BIOPHARMA R&D IP, LLC
901 GATEWAY BOULEVARD, SOUTH SAN FRANCISCO, CALIFORNIA, USA 94080
Covered Properties (15)
Biphenyl compounds useful as muscarinic receptor antagonists
Application: 60/552,443 →
Biphenyl Compounds Useful as Muscarinic Receptor Antagonists
Patent: 8,912,334 →
Application: 14/023,794 →
Publication: US 2014/0171397
Biphenyl Compounds Useful as Muscarinic Receptor Antagonists
Patent: 7,288,657 →
Application: 11/077,433 →
Publication: US 2005/0203133
Biphenyl Compounds Useful as Muscarinic Receptor Antagonists
Patent: 7,491,736 →
Application: 11/880,007 →
Publication: US 2007/0292357
Biphenyl Compounds Useful as Muscarinic Receptor Antagonists
Patent: 7,521,041 →
Application: 11/974,318 →
Publication: US 2008/0095708
Biphenyl Compounds Useful as Muscarinic Receptor Antagonists
Patent: 7,550,595 →
Application: 11/880,002 →
Publication: US 2007/0292356
Biphenyl Compounds Useful as Muscarinic Receptor Antagonists
Patent: 7,585,879 →
Application: 11/879,996 →
Publication: US 2007/0265305
Biphenyl Compounds Useful as Muscarinic Receptor Antagonists
Patent: 7,803,812 →
Application: 12/437,766 →
Publication: US 2009/0226379
Biphenyl Compounds Useful as Muscarinic Receptor Antagonists
Patent: 7,910,608 →
Application: 11/879,835 →
Publication: US 2009/0018165
Biphenyl Compounds Useful as Muscarinic Receptor Antagonists
Patent: 8,017,783 →
Application: 11/899,181 →
Publication: US 2008/0071088
Biphenyl Compounds Useful as Muscarinic Receptor Antagonists
Patent: 8,034,946 →
Application: 12/814,629 →
Publication: US 2010/0249421
Biphenyl Compounds Useful as Muscarinic Receptor Antagonists
Patent: 8,053,448 →
Application: 13/024,532 →
Publication: US 2011/0130422
Biphenyl Compounds Useful as Muscarinic Receptor Antagonists
Patent: 8,173,815 →
Application: 13/226,677 →
Publication: US 2011/0319625
Biphenyl Compounds Useful as Muscarinic Receptor Antagonists
Patent: 8,273,894 →
Application: 13/438,105 →
Publication: US 2012/0190657
Biphenyl Compounds Useful as Muscarinic Receptor Antagonists
Patent: 8,557,997 →
Application: 13/592,713 →
Publication: US 2013/0172301
Related Assignments (3)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jun 4, 2004
From: MAMMEN, MATHAI; JI, YU-HUA; MU, YONGQI; HUSFELD, CRAIG
To: THERAVANCE, INC.
Reel/Frame 014708/0848 →
Assignment of Assignor's Interest Mar 10, 2005
From: MAMMEN, MATHAI; JI, YU-HUA; MU, YONGQI; HUSFELD, CRAIG
To: THERAVANCE, INC.
Reel/Frame 016375/0023 →
Security Interest Sep 24, 2026
From: THERAVANCE BIOPHARMA R&D IP, LLC
To: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION
Reel/Frame 076134/0790 →